Start for free
Start for free
VC

Velan Capital

North America, Georgia, United States, Alpharetta

Description

Velan Capital invest in public development-stage and commercial-stage companies.

Investor Profile

Velan Capital has made 11 investments, with 2 in the past 12 months and 9% as lead.

Stage Focus

  • Post Ipo Equity (100%)

Country Focus

  • United States (82%)
  • Israel (9%)
  • Canada (9%)

Industry Focus

  • Biotechnology
  • Health Care
  • Therapeutics
  • Pharmaceutical
  • Biopharma
  • Medical
  • Medical Device
  • Health Diagnostics
  • Clinical Trials
  • Manufacturing
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Velan Capital frequently co-invest with?

Abingworth
Abingworth
Europe, England, United Kingdom, London
Co-Investments: 2
Nantahala Capital Management
Nantahala Capital Management
North America, Connecticut, United States, New Canaan
Co-Investments: 5
Qiming Venture Partners USA
Qiming Venture Partners USA
North America, Massachusetts, United States, Cambridge
Co-Investments: 2
Woodline Partners
Woodline Partners
North America, California, United States, San Francisco
Co-Investments: 3
Great Point Partners
Great Point Partners
North America, Connecticut, United States, Greenwich
Co-Investments: 3
Soleus Capital
Soleus Capital
North America, Connecticut, United States, Greenwich
Co-Investments: 2
Vivo Capital
Vivo Capital
North America, California, United States, Palo Alto
Co-Investments: 2
SC
Stonepine Capital Management
North America, Oregon, United States, Bend
Co-Investments: 3
Kingdon Capital
Kingdon Capital
North America, New York, United States, New York
Co-Investments: 2
Boxer Capital
Boxer Capital
North America, Florida, United States, Windermere
Co-Investments: 2

What are some of recent deals done by Velan Capital?

Edesa Biotech

Markham, Ontario, Canada

Edesa develops treatments for dermatological and anorectal diseases. Edesa merged with Stellar Biotechnologies in 2019.

BiotechnologyLife Science
Post Ipo EquityFeb 13, 2025
Amount Raised: $10,509,103
Tenax Therapeutics

Chapel Hill, North Carolina, United States

Tenax Therapeutics focuses on identifying and developing treatments that address cardiovascular and pulmonary diseases.

BiotechnologyHealth CareTherapeutics
Post Ipo EquityAug 6, 2024
Amount Raised: $100,000,000
Protara Therapeutics

New York, New York, United States

Protara Therapeutics develops transformative therapies for people with cancer and rare diseases with limited treatment options.

BiotechnologyHealth CareTherapeutics
Post Ipo EquityApr 5, 2024
Amount Raised: $45,000,000
Unicycive Therapeutics

Los Altos, California, United States

Unicycive Therapeutics provides development programs that focus on treating kidney diseases with unmet medical needs.

BiotechnologyHealth CareHealth DiagnosticsMedical
Post Ipo EquityMar 14, 2024
Amount Raised: $50,000,000
Jasper Therapeutics

Redwood City, California, United States

Jasper Therapeutics is a biotechnology company that develops novel antibody therapies for stem cell transplants.

BiotechnologyHealth CarePharmaceuticalTherapeutics
Post Ipo EquityFeb 6, 2024
Amount Raised: $50,000,000
Kiora Pharmaceuticals

Salt Lake City, Utah, United States

Kiora Pharmaceuticals develops medicines to treat eye diseases using its non-invasive, iontophoretic drug-delivery system.

BiotechnologyMedicalPharmaceutical
Post Ipo EquityJan 31, 2024
Amount Raised: $15,000,000
Outlook Therapeutics

Iselin, New Jersey, United States

Outlook Therapeutics is a biopharmaceutical company that develops ophthalmic formulations.

BiopharmaBiotechnologyPharmaceuticalTherapeutics
Post Ipo EquityJan 23, 2024
Amount Raised: $65,000,000
enVVeno Medical

Irvine, California, United States

enVVeno Medical is a clinical-stage medical device company focused on the advancement of innovative bioprosthetic solutions.

Clinical TrialsManufacturingMedical Device
Post Ipo EquityOct 6, 2023
Amount Raised: $28,000,000
Heron Therapeutics

Redwood City, California, United States

Heron Therapeutics is a biotechnology firm specializing in polymer-based pharmaceuticals.

BiotechnologyHealth CareTherapeutics
Post Ipo EquityJul 24, 2023
Amount Raised: $30,000,000
InspireMD

Tel Aviv, Tel Aviv, Israel

InspireMD is a medical device company focusing on the development and commercialization of its proprietary stent system technology, MGuard.

BiopharmaBiotechnologyHealth CareMedical Device
Post Ipo EquityMay 15, 2023
Amount Raised: $113,600,000
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsPricing

Free tools

Pre-Money and Post-Money Valuation Calculator